…
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd was founded in 2018 and is headquartered in Subiaco, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on ECS Botanics Holdings Ltd is limited; filings indicate it operates in botanical and hemp-derived products, including cannabidiol (CBD) formulations. Long-term growth may be supported by rising demand for regulated natural health products, product diversification and potential export opportunities, which may appeal to investors seeking botanical/CBD exposure.
Principal risks are regulatory and legislative changes for cannabinoid products, execution and scale-up challenges, competitive market pressure and potential financing or liquidity constraints.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -1.03M | -6.91M | 1.84M | 0.49M | -1.14M |
| Net income | -1.91M | -5.73M | 1.92M | -0.08M | -1.15M |
| Selling general administrative | - | 2.11M | 1.93M | 1.80M | 2.12M |
| Selling and marketing expenses | - | 1.09M | 4.13M | 3.24M | 0.18M |
| Gross profit | 0.08M | 5.63M | 9.13M | 6.04M | 3.41M |
| Reconciled depreciation | - | - | 1.32M | 1.04M | 0.76M |
| Ebit | -6.65M | -3.66M | 1.91M | 1.26M | -0.04M |
| Ebitda | -5.55M | -2.22M | 3.23M | 2.30M | 0.73M |
| Depreciation and amortization | 1.10M | 1.44M | 1.33M | 1.04M | 0.76M |
| Operating income | -6.65M | -8.63M | -0.67M | 0.51M | 0.18M |
| Other operating expenses | 27.67M | 23.18M | 20.70M | 5.27M | 0.51M |
| Interest expense | 0.51M | 0.31M | 0.06M | 0.04M | 0.00M |
| Tax provision | - | -1.18M | -0.07M | 0.00M | 0.01M |
| Interest income | - | 0.31M | 0.04M | 0.04M | 0.00M |
| Net interest income | - | - | -0.03M | -0.02M | 0.00M |
| Extraordinary items | - | - | 0.00M | -0.57M | -1.28M |
| Income tax expense | 0.87M | 1.18M | -0.07M | 0.87M | 0.01M |
| Total revenue | 21.02M | 19.36M | 20.03M | 15.39M | 6.78M |
| Total operating expenses | 6.73M | 9.45M | 2.65M | 6.11M | 4.24M |
| Cost of revenue | 20.94M | 13.73M | 18.05M | 9.35M | 3.36M |
| Total other income expense net | 5.62M | 1.72M | 2.51M | -0.47M | -0.32M |
| Discontinued operations | - | - | - | -0.57M | -1.28M |
| Net income from continuing ops | - | - | 1.92M | 0.49M | -1.15M |
| Net income applicable to common shares | - | -5.73M | 1.92M | -0.08M | -1.15M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 31.64M | 33.64M | 32.88M | 26.13M | 23.82M |
| Intangible assets | 0.14M | - | - | 2.51M | 3.67M |
| Other current assets | 0.47M | 1.49M | 1.67M | 1.06M | 0.04M |
| Total liab | 8.91M | 11.02M | 4.67M | 3.93M | 1.65M |
| Total stockholder equity | 22.73M | 22.63M | 28.21M | 22.20M | 22.17M |
| Other current liab | 0.92M | 1.58M | 1.07M | 0.87M | 0.17M |
| Common stock | 38.58M | 36.67M | 36.53M | 32.79M | 32.79M |
| Capital stock | - | - | - | 32.79M | 32.79M |
| Retained earnings | -16.24M | -14.36M | -8.66M | -10.95M | -10.90M |
| Other liab | - | - | - | - | -0.00M |
| Good will | - | - | - | 1.05M | 1.05M |
| Other assets | - | - | - | 0.88M | -0.00M |
| Cash | 1.69M | 0.37M | 3.16M | 2.54M | 1.87M |
| Cash and equivalents | - | - | - | - | 1.87M |
| Total current liabilities | 5.46M | 9.37M | 3.88M | 3.66M | 1.65M |
| Current deferred revenue | 0.16M | - | 0.41M | 0.99M | 0.52M |
| Net debt | 5.19M | 6.51M | -2.13M | -2.21M | -1.61M |
| Short term debt | 3.54M | 5.23M | 0.24M | 0.07M | 0.26M |
| Short long term debt | - | - | - | - | 0.24M |
| Short long term debt total | 6.88M | 6.88M | 1.02M | 0.33M | 0.26M |
| Other stockholder equity | - | - | - | -21.84M | -21.92M |
| Property plant equipment | - | - | - | 7.57M | 5.21M |
| Total current assets | 18.82M | 18.92M | 19.68M | 14.11M | 14.91M |
| Long term investments | - | - | - | - | 0.03M |
| Net tangible assets | - | - | - | 18.64M | 18.46M |
| Short term investments | - | - | - | 1.06M | 1.06M |
| Net receivables | 1.89M | 2.21M | 1.79M | 2.55M | 2.18M |
| Inventory | 14.76M | 14.84M | 13.07M | 7.97M | 6.09M |
| Accounts payable | 0.84M | 2.56M | 2.16M | 1.74M | 0.70M |
| Accumulated other comprehensive income | 0.38M | 0.32M | 0.34M | 0.36M | 0.25M |
| Non currrent assets other | - | 1.33M | 3.26M | -11.13M | -0.00M |
| Non current assets total | 12.82M | 14.73M | 13.20M | 12.01M | 8.91M |
| Capital lease obligations | - | - | - | 0.33M | 0.02M |
| Long term debt total | - | - | - | 0.26M | 0.00M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | - | -2.39M | -0.04M | -3.86M |
| Change to liabilities | - | - | - | 1.22M | -2.28M |
| Total cashflows from investing activities | -1.02M | -3.57M | -2.39M | -0.04M | -3.86M |
| Net borrowings | - | - | 0.86M | 0.31M | -0.01M |
| Total cash from financing activities | 1.83M | 5.86M | 4.49M | 0.31M | 6.19M |
| Change to operating activities | - | - | - | 1.24M | 0.25M |
| Net income | -1.91M | -5.73M | 1.92M | -0.08M | -1.12M |
| Change in cash | 1.32M | -2.78M | 0.62M | 0.68M | -2.38M |
| Begin period cash flow | 0.37M | 3.16M | 2.54M | 1.87M | 4.24M |
| End period cash flow | 1.69M | 0.37M | 3.16M | 2.54M | 1.87M |
| Total cash from operating activities | 0.51M | -5.07M | -1.49M | 0.40M | -4.71M |
| Issuance of capital stock | - | - | 3.80M | - | 6.20M |
| Depreciation | 1.10M | 1.44M | 1.33M | 1.04M | 0.76M |
| Other cashflows from investing activities | - | - | 0.00M | 3.26M | 0.56M |
| Change to inventory | 0.28M | -1.97M | -5.11M | 0.65M | -0.03M |
| Change to account receivables | -0.22M | -0.79M | 0.40M | -1.28M | -1.32M |
| Sale purchase of stock | - | 0.00M | 3.80M | 0.00M | 6.20M |
| Other cashflows from financing activities | -0.98M | 6.28M | -0.17M | 0.31M | -0.01M |
| Change to netincome | - | - | - | -2.38M | -0.95M |
| Capital expenditures | 1.02M | 3.57M | 2.39M | 3.30M | 2.92M |
| Change in working capital | -0.61M | 0.74M | -4.97M | -0.64M | -1.35M |
| Stock based compensation | - | 0.15M | 0.21M | 0.11M | - |
| Other non cash items | 1.93M | -1.67M | 0.02M | -0.56M | -3.01M |
| Free cash flow | -0.51M | -8.64M | -3.88M | -2.90M | -7.63M |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ECS ECS Botanics Holdings Ltd |
-0.00 20.00% |
0.00 | - | 5.67 | 0.38 | 0.35 | 0.61 | 21.91 |
| AFP Aft Pharmaceuticals Ltd |
0.05 1.41% |
3.60 | 29.92 | 18.18 | 1.48 | 4.37 | 2.05 | 18.56 |
| VLS Vita Life Sciences Ltd |
0.09 3.42% |
2.72 | 13.50 | 42.73 | 1.52 | 2.62 | 1.19 | 7.17 |
| LGP Little Green Pharma Ltd |
0.01 16.67% |
0.07 | - | 10.00 | 0.64 | 0.60 | 1.25 | 19.47 |
| MVP Medical Developments International Ltd |
- -% |
0.44 | 40.00 | 166.67 | 1.06 | 0.79 | 0.57 | 7.45 |
ECS Botanics Holdings Ltd engages in the cultivation, manufacture, and sale of medicinal cannabis products in Australia and internationally. It is involved in the agriculture business. ECS Botanics Holdings Ltd was founded in 2018 and is headquartered in Subiaco, Australia.
| Name | Title | Year Born |
|---|---|---|
| Ms. Nan-Maree Schoerie Dip Chem | MD & Exec. Director | NA |
| Mr. Alexander Keach | Founder, Head of Corp. Relations & Exec. Director | NA |
| Ms. Nikki Cranley | Financial Controller | NA |
| Mr. Arthur Sun | Financial Controller | NA |
| Mr. Jason Hine | Chief Operations Officer | NA |
| Ms. Sally Allport | Exec. Assistant to MD & Marketing Mang. | NA |
| Mr. Michael Clark | Head of European Operations | NA |
| Mr. Mauro Piccini | Company Sec. | NA |
| Ms. Nan-Maree Schoerie Dip Chem | MD & Executive Director | NA |
| Mr. Alexander Keach | Founder & Non-Executive Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.